IRIS
MINGARI, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 37.614
AS - Asia 143
SA - Sud America 81
NA - Nord America 9
AF - Africa 1
Totale 37.848
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 37.612
CN - Cina 81
BR - Brasile 67
VN - Vietnam 34
SG - Singapore 19
ID - Indonesia 5
US - Stati Uniti d'America 5
AR - Argentina 4
CO - Colombia 4
EC - Ecuador 4
DO - Repubblica Dominicana 2
PY - Paraguay 2
FI - Finlandia 1
GT - Guatemala 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MX - Messico 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 37.848
Salva come PNG Salva come JPEG
Città #
Genova 24.564
Genoa 7.699
Rapallo 2.949
Vado Ligure 2.348
Bordighera 52
Beijing 38
Ho Chi Minh City 12
Hanoi 8
Ashburn 5
Ribeirão Preto 4
Curitiba 3
Quito 3
Rio de Janeiro 3
Singapore 3
Vinh 3
Asunción 2
Caxias do Sul 2
Duque de Caxias 2
São Paulo 2
Viamão 2
Aktau 1
Amman 1
Apóstoles 1
Armação dos Búzios 1
Barretos 1
Biên Hòa 1
Bogotá 1
Brasília 1
Braço do Norte 1
Cabo de Santo Agostinho 1
Campinas 1
Cape Town 1
Caraguatatuba 1
Carmópolis de Minas 1
Colônia do Piauí 1
Cà Mau 1
Da Nang 1
Divinópolis 1
Estância 1
Fortaleza 1
Guaduas 1
Guarulhos 1
Guatemala City 1
Haiphong 1
Hortolândia 1
Hưng Yên 1
Ipatinga 1
Jakarta 1
Joinville 1
Jundiaí 1
Lajeado 1
Lappeenranta 1
Lauro de Freitas 1
Llambí Campbell 1
Lấp Vò 1
Magé 1
Manaus 1
Mar del Plata 1
Marília 1
Medan 1
Montes Claros 1
Ninh Bình 1
Niterói 1
Olinda 1
Osasco 1
Palmeira dos Índios 1
Pindamonhangaba 1
Porto Alegre 1
Portoviejo 1
Praia Grande 1
Presidente Prudente 1
Redenção 1
Ribeirão 1
Riga 1
Rio Branco 1
Rio Pomba 1
Rondonópolis 1
Salvador 1
Santa Rita do Sapucaí 1
Santana de Parnaíba 1
Santo Domingo 1
Santos 1
Sardoá 1
Serra 1
Soacha 1
Sorocaba 1
São José 1
São Leopoldo 1
São Mateus 1
Taquarussu 1
Tashkent 1
Thái Nguyên 1
Tuxtla Gutiérrez 1
Tây Ninh 1
Vargem Grande Paulista 1
Vila Valério 1
Vũng Tàu 1
Zárate 1
Totale 37.782
Salva come PNG Salva come JPEG
Nome #
Mesenchymal stem cell-Natural Killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. 297
Identification of cytomegalovirus (CMV)-specific T lymphocytes displaying an effector-memory phenotype that kill CMV-infected target cells in an HLA-E-restricted fashion 234
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function 225
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 206
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112) 198
Internalization via Antennapedia protein transduction domain of an scFv antibody toward c-Myc protein 196
T cell nature of some lymphokine-activated killer (LAK) cells. Frequency analysis of LAK precursors within human T cell populations and clonal analysis of LAK effector cells. 193
Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function 191
Role of the calpain-calpastatin system in the density-dependent growth arrest 181
NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation. 179
B cell growth factor activity of immunoaffinity-purified and recombinant human interleukin 2. 177
Human NK cells at early stages of differentiation produce large amounts of CXCL8 and express CD161 molecule that that functions as an activating receptor 173
Anticorpo ricombinante umano e suo uso per l’ identificazione del sindecano-1 a scopo diagnostico e terapeutico 172
Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function. 169
Effect of tumor cells and tumor microenvironment on NK-cell function. 169
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment 169
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias 168
Unique Eomes+ NK cell subsets are present in uterus and decidua during early pregnancy 168
Characterization of the calpain/calpastatin system in human hemopoietic cell lines 165
IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors 164
Human innate lymphoid cells 163
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK cell function 162
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2 162
Markers and function of human NK cells in normal and pathological conditions 160
Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NK p30 159
Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages 159
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. 158
Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression 158
Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors. 157
Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor 157
CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. 156
NCR + ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures 155
Stimulatory receptors in NK and T cells. 154
Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis. 153
NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines 153
Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. 152
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation 152
Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15. 152
4F2 monoclonal antibody recognizes a surface antigen on spread human fibroblasts of embryonic but not of adult origin. 151
Surface antigens specifically expressed by activated T cells in humans. 151
Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts 151
Human NK receptors: from the molecules to the therapy of high risk leukemias. 151
"Physiological and Pathological Aspects of Human NK Cells" 150
Development of human natural killer cells and other innate lymphoid cells. 150
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 149
Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation. 149
MSC and innate immune cell interactions: A lesson from human decidua 149
Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors. 149
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. 149
HO-1 downregulation favors BRAFV600 melanoma cell death induced by Vemurafenib/PLX4032 and increases NK recognition 148
T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. 147
Characterization of human afferent lymph dendritic cells from seroma fluids. 147
Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells. 146
Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: Engagement of CD33 induces apoptosis of leukemic cells 146
Surface receptors that regulate the NK cell function: beyond the NK cell scope. 145
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. 145
Cytolytic T lymphocytes displaying Natural Killer (NK)-like activity. Expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production 144
In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors. 144
NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation 144
Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients 144
Stromal cells from human decidua exert a strong inhibitory effect on NK cell function and dendritic cell differentiation 143
Regulation of myeloid cell proliferation and survival by p75/AIRM1 and CD33 surface receptors. 143
Immunobiology of human NK cells. 142
Surface markers of cloned human T cells with helper or suppressor activity on pokeweed mitogen-driven B cell differentiation. 142
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 141
Origin, phenotype and function of human natural killer cells in pregnancy. 141
In vivo generation of decidual Natural Killer cells from resident hematopoietic progenitors. 141
Expression of HLA-class I-specific inhibitory Natural Killer cell receptors in HIV-specific cytolytic T lymphocytes. Impairment of specific cytolytic functions. 139
Role of Ia Antigens in the human autologous mixed lymphocyte reaction. 139
Surface receptors and functional interactions of human natural killer cells: from bench to the clinic 139
Effect of superantigens on human thymocytes: selective proliferation of V beta 2+ cells in response to toxic shock syndrome toxin-1 and their deletion upon secondary stimulation 138
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis 137
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? 136
HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. 136
Effect of tyrosin kinase inhibitors on NK Cell and ILC3 development and function 136
Anticlonotypic monoclonal antibodies induce proliferation of clonotype-positive T cells in peripheral blood human T lymphocytes. Evidence for a phenotypic (T4/T8) heterogeneity of the clonotype-positive proliferating cells. 135
Clonal heterogeneity in the requirement for T3, T4, and T8 molecules in human cytolytic T lymphocyte function. 135
Surface markers of resting and activated human T cells. Functional implications and experimental limits. 135
HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. 134
Understanding human NK cell differentiation: clues for improving the haploidentical hematopoietic stem cell transplantation. 134
Il-1β-Releasing human acute myeloid leukemia blasts modulate natural killer cell differentiation from cd34+ precursors 134
Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients 134
Thymic origin of some natural killer cells: clonal proliferation of human CD3-16+ cells from CD3-4-8- thymocyte precursors requires the presence of H9 leukemic cells. 134
Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells 134
Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: a regulated mechanism that controls T-cell activation and function. 133
IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid 133
Dendritic cells efficiently cross-prime HLA class I restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates. 132
Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition 132
Natural killer alloeffector responses in haploidentical hemopoietic stem cell transplantation to treat high-risk leukemias. 131
Seroma fluid subsequent to axillary lymph node dissection for breast cancer derives from an accumulation of afferent lymph. 131
Comparative analysis of NK- or NK-CTL-mediated lysis of immature or mature autologous dendritic cells 131
Immune response in the conjunctival epithelium of patients with dry eye. 131
HLA-class I-specific inhibitory receptors of NK type on a subset of human T cells. 130
Analysis of the circulating Th1/Th17 lymphocyte repertoire after hematopoietic stem cell transplant may reveal opportunistic fungal infections rather than GvHD reaction 130
Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells 130
Human natural killer cells: their origin, receptors and function 129
Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. 129
Frequent coexpression of cytolytic activity and lymphokine production among human T lymphocytes. Production of B cell growth factor and interleukin 2 by T8+ and T4+ cytolytic clones. 129
Role of major histocompatibility complex class I expression and natural killer-like T cells in the genetic control of endometriosis. 129
Human peripheral blood lymphocytes bearing T cell receptor gamma/delta. Expression of CD8 differentiation antigen correlates with the expression of the 55-kD, C gamma 2-encoded gamma chain. 129
Totale 15.256
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.207
article - articoli 116.948
book - libri 0
conference - conferenze 1.791
curatela - curatele 0
other - altro 0
patent - brevetti 675
selected - selezionate 0
volume - volumi 1.793
Totale 242.414
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.650 0 0 0 0 178 219 104 214 239 274 213 209
2021/20224.034 129 283 374 399 202 205 243 962 165 392 172 508
2022/20233.533 375 227 63 324 569 697 2 266 602 13 352 43
2023/20241.857 118 248 49 251 174 336 73 88 125 45 95 255
2024/20255.412 99 431 193 338 884 549 498 785 222 256 464 693
2025/20262.516 1.058 213 504 721 20 0 0 0 0 0 0 0
Totale 38.314